The city of Lansing, Michigan, currently has 3 active clinical trials seeking participants for Arthritis research studies.
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
Recruiting
This Phase 2b, multicenter, double-blind, placebo-controlled, randomized withdrawal study is designed to assess the efficacy and safety of IMVT-1402 in adult participants with active, difficult-to-treat, anti-citrullinated protein autoantibody (ACPA) positive rheumatoid arthritis (RA). The primary objective is to evaluate the effects of IMVT-1402 compared to placebo, as measured by the American College of Rheumatology 20% (ACR20) response.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/01/2025
Locations: Site Number - 1009, Lansing, Michigan
Conditions: Rheumatoid Arthritis
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
Recruiting
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/26/2024
Locations: Sunpharma site no. 10, Lansing, Michigan
Conditions: Active Psoriatic Arthritis
Triathlon All-Polyethylene Tibia Outcomes Study
Recruiting
The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/19/2024
Locations: Michigan Orthopaedic Center, Lansing, Michigan
Conditions: Arthropathy of Knee, Replacement, Knee Arthritis